References
- Erdö F, Trapp T, Mies G, Immunohistochemical analysis of protein expression after middle cerebral artery occlusion in mice. Acta Neuropathol 2004;107(2):127–36.
- Ahn YH, Lee G, Kang SK. Molecular insights of the injured lesions of rat spinal cords: inflammation, apoptosis, and cell survival. Biochem Biophys Res Commun 2006;348(2):560–70.
- Takagi Y, Harada J, Chiarugi A, STAT1 is activated in neurons after ischemia and contributes to ischemic brain injury. J Cereb Blood Flow Metab 2002;22 (11):1311–8.
- Dziennis S, Alkayed NJ. Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 2008;19(4–5):341–61.
- Ehrenreich H, Weissenborn K, Prange H, Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 2009;40(12):647–56.
- Yang YL, Zhu WX, Chen YH, Protection of erythropoietin on cerebral ischemia/reperfusion injury. Chinese J Appl Physiol 2010;26(2):152–3.
- Kretz A, Happold CJ, Marticke JK, Erythropoietin promotes regeneration of adult CNS neurons via Jak2/Stat3 and PI3K/AKT pathway activation. Mol Cell Neurosci 2005;29(4):569–79.
- Kisseleva T, Bhattacharya S, Braunstein J, Signaling through the JAK-STAT pathway: recent advances and future challenges. Gene 2002;285(1):1–24.
- Hara H, Friedlander RM, Gagliardini V, et al. Inhibition of interleukin-1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 1997;94:2007–12.
- Shen JF, Wu YL, Xu JY, ERK and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl–xL, Bax, and BAD. Invest Ophthalmol Vis Sci 2010;51(2):35–46.
- Kumral A, Genc S, Ozer E, Erythropoietin downregulates Bax and DP5 proapoptotic gene expression in neonatal hypoxic–ischemic brain injury. Biol Neonate 2005;89(3):205–10.
- Sigore AP, Weng Z, Hastings T, Erythropoietin protects against 6-hydroxdopamine-induced dopaminergic cell death. J Neurochem 2006;96(2):428–43.
- Zechariah A, Elali A, Hermann DM. Combination of tissue-plasminogen activator with erythropoietin induces blood–brain barrier permeability, extracellular matrix disaggregation, and DNA fragmentation after focal cerebral ischemia in mice. Stroke 2010;41(5):1008–12.
- Ferrer I, Plans AM. Signaling of cell death and cell survival following focal cerebral ischemia: life and death struggle in the penumbra. J Neurol Exp Neuro 2003;62(4):329–39.
- Kim HS, Lee MS. STAT1 as a key modulator of cell death. Cell Signal, 2007;19(3):454–65.
- Lim CP, Cao X. Structure, function, and regulation of STAT proteins. Mol Biosyst 2006;2(11):536–50.
- Amantea D, Tassorelli C, Russo R, Neuroprotection by leptin in a rat model of permanent cerebral ischemia: effects on STAT3 phosphorylation in discrete cells of the brain. Cell Death Dis 2011;2:e238.
- Xie HF, Xu RX, Wei JP, P-JAK2 and P-STAT3 protein expression and cell apoptosis following focal cerebral ischemia–reperfusion injury in rats. J South Med Univ 2007;2(27):208–11.
- Li Y, Lu Z, Keogh CL, Erythropoietin-induced neurovascular protection, angiogenesis, and cerebral blood flow restoration after focal ischemia in mice. J Cereb Blood Flow Metab 2007;27(5):1043–54.
- Qin H, Niyongere SA, Lee SJ, Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J Immunol 2008;181(5):3167–76.